Rayner Newsroom

Rayner appoints Darren Millington as Chief Finance Officer (CFO) and Board member.

Darren has several years’ experience in CFO roles and running international businesses at Board level. Most recently he was at Gama Aviation, an aviation and engineering company and before that at Summit Corporation who specialise in developing drugs for muscular dystrophy and TB.

Professor Gerd Auffarth, Professor Oliver Findl, Professor Michael Amon and Doctor Victor Antunes complete the panel of presenters who make up the symposium ‘Maximising treatment outcomes with premium IOL technologies’, an education program sponsored by Rayner in conjunction with Eurotimes at the XXXII Congress of ESCRS, 13-17 September.

ESCRS delegates will be exposed to these surgeons contributing to this topic based on their area of expertise:

Professor Gerd Auffarth
C-flex and Superflex: the benefits of aberration-neutral technology

The recent Jan Venter (MD, Clinic Director of the Optical Express International Medical Advisory Board) article provides further evidence of the predictability of the Sulcoflex® Aspheric in correcting refractive surprises.

Residual refractive error has a major impact on patient satisfaction, and lens exchange or excimer laser may not be a viable option to correct ametropia in these dissatisfied patients. Dr Venter’s paper provides evidence of the effectiveness of Sulcoflex Aspheric in correcting these refractive surprises in a large cohort of patients (80 eyes in 64 patients). 

Rayner proudly announced today that the T-flex Aspheric Toric intraocular lens (IOL) has received Chinese Food and Drug Administration (CFDA) approval and is being launched in China.

Product Approval Details

The CFDA granted regulatory approval and sale of the T-flex Aspheric Toric IOL (623T) in the following power range:

Spheres: -10.0 to +24.0 D in 0.5 D steps
Cylinders: +1.0 to +11.0 D in 0.5 D steps

Professor Gerd Auffarth, Professor Oliver Findl, Professor Wolfgang Haigis, Professor Michael Amon and Professor Thomas Kohnen are just a few of the surgeons who presented at the annual Rayner forum in Vienna, Austria from the 25-27 July.

Rayner announces the re-launch of its new fully-featured website, rayner.com.

The company site has been given a dramatic makeover both visually and also for user navigation to facilitate an easier and more engaging learning experience.

An article by Julian Cezon, MD, explores the use of toric IOLs in patients with stable (non-progressive) kerataconus:
Cataract Surgery in Eyes with Nonprogressive Kerataconus: Toric IOLs can provide excellent outcomes in carefully selected patients. 

Marketing Announcement

Rayner announces the launch of its new injector RaySert®PLUS designed for safe and effective implantations through a 2.2mm wound assisted mini incision.

Rayner complete acquisition of its exclusive distributor in Germany and Austria.
Having its headquarters in Bamberg (Germany), the company was previously partially owned by the Rayner group.